Comment from LUNGevity Foundation

Summary: The LUNGevity Foundation, a lung cancer nonprofit, supports the draft guidance on protocol deviations, noting that some flexibility is appropriate for maintaining trial integrity. They request additional clarification on how the volume and level (e.g., patient vs. site) of deviations impact their classification as "important" and suggest refining reporting requirements to avoid undue burdens for minor deviations.